Metraipolis › archive › dc_2db4627fbc37

Proactive, short-term PCSK9 inhibition after PCI in patients with coronary artery disease at high residual risk: rationale and design of the randomized… — Europe PMC PMID:41847515

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41847515
DOI
10.3389/fcvm.2026.1761093
License (as archived)
solo-consultazione
Archived
2026-11-05T09:44:19.892Z
SHA-256 of the archived text
6b02aa5f5626668d92683d490d030a5495d85cbe91c93c7e2568becb677c0a65
Stable URL of this page
https://metraipolis.com/documento/dc_2db4627fbc37

How to cite

Proactive, short-term PCSK9 inhibition after PCI in patients with coronary artery disease at high residual risk: rationale and design of the randomized… — Europe PMC PMID:41847515 — Europe PMC (en), https://europepmc.org/article/MED/41847515 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2db4627fbc37 (Metraipolis archive dc_2db4627fbc37, sha256 6b02aa5f5626668d92683d490d030a5495d85cbe91c93c7e2568becb677c0a65)
BibTeX
@misc{dc2db4627fbc37,
  title = {Proactive, short-term PCSK9 inhibition after PCI in patients with coronary artery disease at high residual risk: rationale and design of the randomized… — Europe PMC PMID:41847515},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41847515},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2db4627fbc37; sha256 6b02aa5f5626668d92683d490d030a5495d85cbe91c93c7e2568becb677c0a65},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41847515. Agents can read the archived copy with the MCP tool read_document.